Deslanoside CAS No. 17598-65-1

Product Description

For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.

Deslanoside is available in injectable form.

Deslanoside inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular Sodium and Calcium concentrations. Increased intracellular concentrations of Calcium may promote activation of contractile proteins (e.g., actin, myosin). Deslanoside also acts on the electrical activity of the heart, increasing the slope of phase 4 depolarization, shortening the action potential duration, and decreasing the maximal diastolic potential.